Analytical Data
-
基因名
pKIWI502
- Application
-
别名
pKIWI502; Fruit protein pKIWI502
-
种属
Actinidia deliciosa
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P43394
-
表达区间
1-317aa
-
分子量
51.2 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
pKIWI502 is a recombinant protein that serves as a pivotal component in various biotechnological and medical research applications. This protein is derived from a specific gene sequence designed to facilitate the study of protein function and interactions in cellular processes. The background of pKIWI502 research is rooted in the growing need for effective tools to investigate protein dynamics and their role in diseases. As researchers aim to understand complex biological systems, the development of recombinant proteins like pKIWI502 offers a pathway to elucidating mechanisms at the molecular level. Additionally, the expression of pKIWI502 in host cells can help in producing large quantities of the protein, enabling in-depth studies related to its structure, dynamics, and potential therapeutic applications. This research aligns with the broader goals of protein engineering and synthetic biology, which seek to harness proteins for tailored solutions in drug design, diagnostics, and treatment strategies. As such, pKIWI502 not only contributes to fundamental research but also holds promise for innovative approaches in addressing health challenges through biomedicine.
